These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18535600)

  • 1. Graves' orbitopathy: frequency of ocular hypertension and glaucoma.
    da Silva FL; de Lourdes Veronese Rodrigues M; Akaishi PM; Cruz AA
    Eye (Lond); 2009 Apr; 23(4):957-9. PubMed ID: 18535600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular hypertension and glaucoma in Graves' orbitopathy.
    Kittisupamongkol W
    Eye (Lond); 2010 Apr; 24(4):742-3; author reply 743. PubMed ID: 19575035
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy.
    Behrouzi Z; Rabei HM; Azizi F; Daftarian N; Mehrabi Y; Ardeshiri M; Mohammadpour M
    J Glaucoma; 2007; 16(4):358-62. PubMed ID: 17570998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy.
    Skalicky SE; Borovik AM; Masselos K; Pandya VB; Wang LW; Figueira EC; Wilcsek G; Francis IC
    J Glaucoma; 2008; 17(3):249; author reply 249-50. PubMed ID: 18414116
    [No Abstract]   [Full Text] [Related]  

  • 5. Focusing on patients at high-risk for glaucoma in Brazil: a pilot study.
    Guedes RA; Guedes VM; Chaoubah A
    J Fr Ophtalmol; 2009 Nov; 32(9):640-5. PubMed ID: 19854538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of intraocular pressure increase and glaucoma prevalence in thyroid eye disease: a mini-review.
    Haefliger IO; von Arx G; Pimentel AR
    Klin Monbl Augenheilkd; 2010 Apr; 227(4):292-3. PubMed ID: 20408077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal involvement in Graves' orbitopathy: an in vivo confocal study.
    Villani E; Viola F; Sala R; Salvi M; Mapelli C; Currò N; Vannucchi G; Beck-Peccoz P; Ratiglia R
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4574-8. PubMed ID: 20435595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular hypertension and optic neuropathies secondary to dysthyroid orbitopathy: Review of the literature].
    Bellot L; Graber M; Laurent C; Mouriaux F
    J Fr Ophtalmol; 2021 Oct; 44(8):1256-1261. PubMed ID: 34303550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blepharoptosis as a sign of severe Graves' orbitopathy.
    Naseem M; Donker DL; Paridaens D
    Eye (Lond); 2009 Aug; 23(8):1743-4. PubMed ID: 18978721
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiology of the endocrine orbitopathy].
    Cmelo J; Chynoranský M; Podoba J; Benejová Z; Blasková J; Ferková S; Farkasová B; Kalafutová I; Kramplová K; Lacková A; Malacká D; Micevová K; Oláhová S; Petráková E; Podobová M; Prokesová D; Rybár M; Ruzináková S; Smorádková A; Ateklác J; Valásková T; Veres I
    Cesk Slov Oftalmol; 2006 Nov; 62(6):373-80. PubMed ID: 17319168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of orbital decompression in a patient with multiple autoimmune diseases and graves' orbitopathy: a case report and review of literature.
    Sellari-Franceschini S; Bartalena L; Seccia V
    Orbit; 2010 Feb; 29(1):48-50. PubMed ID: 20302412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of Graves ophthalmopathy in north-east Islamic Republic of Iran.
    Razavi ME; Abotoraby RB; Kakhki RD; Ghanavati SZ; Layegh P; Taghavi M; Rajabian MT
    East Mediterr Health J; 2008; 14(4):841-9. PubMed ID: 19166167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Graves' orbitopathy.
    Putta-Manohar S; Perros P
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():182-5. PubMed ID: 20467360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroid patients without Graves' orbitopathy are not at increased risk of developing glaucoma: a nationwide Danish register-based case-control study.
    Brandt F; Thvilum M; Hegedüs L; Brix TH
    Endocrine; 2018 Jan; 59(1):137-142. PubMed ID: 29198022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Graves' ophthalmopathy may be a risk factor for the development of postthyroidectomy hypocalcaemia.
    Hassan I; Danila R; Maurer E; Osei-Agymang T; Zielke A
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):614-8. PubMed ID: 18523918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of diplopia in Graves' orbitopathy].
    Pitchon EM; Klainguti G
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):331-3. PubMed ID: 17458806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence and background of ocular hypertension and low tension glaucoma].
    Shiose Y; Ito T; Komuro K; Amano M
    Nippon Ganka Gakkai Zasshi; 1984 Apr; 88(4):806-13. PubMed ID: 6464902
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolving global risk assessment of ocular hypertension to glaucoma.
    Fechtner RD; Khouri AS
    Curr Opin Ophthalmol; 2007 Mar; 18(2):104-9. PubMed ID: 17301610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of glaucoma in the wroclaw population. The wroclaw epidemiological study.
    Nizankowska MH; Kaczmarek R
    Ophthalmic Epidemiol; 2005 Dec; 12(6):363-71. PubMed ID: 16283988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.